These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24273004)

  • 1. Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats.
    Grossini E; Pollesello P; Bellofatto K; Sigaudo L; Farruggio S; Origlia V; Mombello C; Mary DA; Valente G; Vacca G
    Liver Transpl; 2014 Mar; 20(3):361-75. PubMed ID: 24273004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs.
    Grossini E; Molinari C; Pollesello P; Bellomo G; Valente G; Mary D; Vacca G; Caimmi P
    J Pharmacol Exp Ther; 2012 Aug; 342(2):376-88. PubMed ID: 22566668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms contributing to the protective effect of levosimendan in liver ischemia-reperfusion injury.
    Ibrahim MA; Abdel-Gaber SA; Amin EF; Ibrahim SA; Mohammed RK; Abdelrahman AM
    Eur J Pharmacol; 2014 Oct; 741():64-73. PubMed ID: 25094034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay.
    Grossini E; Bellofatto K; Farruggio S; Sigaudo L; Marotta P; Raina G; De Giuli V; Mary D; Pollesello P; Minisini R; Pirisi M; Vacca G
    PLoS One; 2015; 10(4):e0124742. PubMed ID: 25880552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
    Wang Y; Kudo M; Xu M; Ayub A; Ashraf M
    J Mol Cell Cardiol; 2001 Nov; 33(11):2037-46. PubMed ID: 11708847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
    Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
    Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel.
    Grossini E; Molinari C; Caimmi PP; Uberti F; Vacca G
    Br J Pharmacol; 2009 Jan; 156(2):250-61. PubMed ID: 19154424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
    Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicorandil inhibits hypoxia-induced apoptosis in human pulmonary artery endothelial cells through activation of mitoKATP and regulation of eNOS and the NF-κB pathway.
    Wang H; Zuo X; Wang Q; Yu Y; Xie L; Wang H; Wu H; Xie W
    Int J Mol Med; 2013 Jul; 32(1):187-94. PubMed ID: 23670355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model.
    Das B; Sarkar C
    Vascul Pharmacol; 2007 Oct; 47(4):248-56. PubMed ID: 17728191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of bone marrow-derived endothelial progenitor cells attenuates cerebral ischemia and reperfusion injury by inhibiting neuronal apoptosis, oxidative stress and nuclear factor-κB expression.
    Qiu J; Li W; Feng S; Wang M; He Z
    Int J Mol Med; 2013 Jan; 31(1):91-8. PubMed ID: 23151725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological preconditioning using intraportal infusion of L-arginine protects against hepatic ischemia reperfusion injury.
    Giovanardi RO; Rhoden EL; Cerski CT; Salvador M; Kalil AN
    J Surg Res; 2009 Aug; 155(2):244-53. PubMed ID: 19540520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil elastase contributes to the development of ischemia-reperfusion-induced liver injury by decreasing endothelial production of prostacyclin in rats.
    Okajima K; Harada N; Uchiba M; Mori M
    Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1116-23. PubMed ID: 15246960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats.
    Chander V; Chopra K
    Arch Med Res; 2006 Jan; 37(1):19-26. PubMed ID: 16314181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury.
    Zhang C; Guo Z; Liu H; Shi Y; Ge S
    PLoS One; 2015; 10(1):e0114963. PubMed ID: 25608001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of apelin preconditioning in a rat model of hepatic ischemia reperfusion injury; possible interaction between the apelin/APJ system, Ang II/AT1R system and eNOS.
    Sabry MM; Ramadan NM; Al Dreny BA; Rashed LA; Abo El Enein A
    United European Gastroenterol J; 2019 Jun; 7(5):689-698. PubMed ID: 31210947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver.
    Koti RS; Tsui J; Lobos E; Yang W; Seifalian AM; Davidson BR
    FASEB J; 2005 Jul; 19(9):1155-7. PubMed ID: 15870170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NO donor KMUP-1 improves hepatic ischemia-reperfusion and hypoxic cell injury by inhibiting oxidative stress and pro-inflammatory signaling.
    Kuo KK; Wu BN; Chiu EY; Tseng CJ; Yeh JL; Liu CP; Chai CY; Chen IJ
    Int J Immunopathol Pharmacol; 2013; 26(1):93-106. PubMed ID: 23527712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan modulates programmed forms of cell death through K(ATP) channels and nitric oxide.
    Uberti F; Caimmi PP; Molinari C; Mary D; Vacca G; Grossini E
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):246-58. PubMed ID: 21107279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes.
    Markou T; Makridou Z; Galatou E; Lazou A
    Eur J Pharmacol; 2011 Sep; 667(1-3):298-305. PubMed ID: 21664904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.